Development and Validation of a Discriminatory Dissolution Model for an Immediately Release Dosage Form by DOE and...

Area of Science:

• Pharmaceutical Sciences
• Drug Product Development
• Analytical Chemistry

Background:

• Early-phase drug development often uses non-discriminatory dissolution methods.
• Assessing drug product stability and quality requires sensitive dissolution testing.
• Identifying factors affecting drug dissolution is crucial for formulation development.

Purpose of the Study:

• To build a discriminatory dissolution model for a highly water-soluble immediate-release solid dosage form.
• To define the dissolution operational space capable of differentiating degraded drug products from controls.
• To establish a correlation between discriminatory dissolution and disintegration.

Main Methods:

• Design of Experiments (DOE) for systematic variable screening.
• Multivariate Analysis of Variance (MANOVA) and Multiple Linear Regression (MLR) for modeling.
• Prediction profiler and contour profiler analyses for operational space definition.
• Model-independent statistical analysis (e.g., f2) for validation.
• Correlation analysis between dissolution and disintegration.

Main Results:

• The study successfully developed a discriminatory dissolution model.
• The model identified specific operational parameters influencing dissolution performance.
• The discriminatory dissolution conditions were validated against external data.
• A correlation between discriminatory dissolution and disintegration was established.

Conclusions:

• A robust and discriminatory dissolution method was established for immediate-release solid dosage forms.
• The developed model aids in assessing drug product quality and detecting degradation.
• This approach enhances the understanding of dissolution behavior and its link to disintegration.